Market Overview:
The global serine protein kinase market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of cancer, rising demand for targeted therapies, and growing investments by pharmaceutical companies in R&D activities. Based on type, the global serine protein kinase market is segmented into AZD-0156, AZD-1390, KU-55933, M-3541 and others. Based on application, the market is segmented into colorectal cancer, gastric cancer solid tumor adenocarcinoma and others.
Product Definition:
A serine protein kinase is an enzyme that phosphorylates proteins. This process is important for many cellular processes, including signal transduction and gene expression.
AZD-0156:
It is a novel small molecule inhibitor for the treatment of R/R multiple myeloma and non-small cell lung cancer. AZD-0156 has completed Phase I study in 2014, which was followed by an extensive Phase II trial. The drug has shown encouraging safety and efficacy profile in clinical studies thus far, with no serious side effects reported apart from mild to moderate gastrointestinal issues at the higher dose levels.
AZD-1390:
AZD-1390 is a drug that is developed by AstraZeneca for the treatment of type 2 diabetes and obesity. AZD-1390 has been found to be effective in treating both types of diabetes mellitus, which includes LIPID (Low Insulin Sensitivity and High Blood Pressure), T2DM (type 2 diabetes), and T1DM (type 1 diabetes).
Application Insights:
The application segment includes colorectal cancer, gastric cancer, solid tumor, adenocarcinoma, and others. Among these applications, the market for serine protein kinase is dominated by colorectal cancer due to high prevalence of the disease as well as increasing awareness among people about early detection and treatment. According to data published in 2016 by the World Health Organization (WHO), it has been estimated that globally around 1.3 million people are diagnosed with colorectal cancer annually and over 70% of them are expected to die due to late diagnosis.
Regional Analysis:
North America accounted for the largest share of revenue in 2017. The region is expected to maintain its position during the forecast period owing to increasing R&D activities and high adoption of serine protein kinase inhibitors. Asia Pacific is projected to be the fastest-growing regional market over the forecast period due to rising awareness about oncology drugs, improving healthcare infrastructure, and availability of effective treatment options in emerging countries such as China & India. In addition, low cost of clinical trials in developing nations will boost growth further.
Moreover, growing investment by global players for expansion will drive growth further. For instance, Pfizer Inc., a U.S.-based pharmaceutical company has signed an agreement with Anhui province government for investing around USD X million over a span of 6 years from 2014 in R&D activities related to cancer drug development at Anhui Provincial Institute for Pharmaceutical Sciences (API).
Growth Factors:
- Increasing demand for effective and targeted cancer therapies
- Growing prevalence of cancer
- Rising geriatric population
- Technological advancements in the field of serine protein kinases research 5. increasing investment in serine protein kinase research
Scope Of The Report
Report Attributes
Report Details
Report Title
Serine Protein Kinase Market Research Report
By Type
AZD-0156, AZD-1390, KU-55933, M-3541, Others
By Application
Colorectal Cancer, Gastric Cancer, Solid Tumor, Adenocarcinoma, Others
By Companies
AstraZeneca Plc, InteRNA Technologies BV, Merck KGaA, Shuttle Pharmaceuticals LLC, AstraZeneca Plc
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
132
Number of Tables & Figures
93
Customization Available
Yes, the report can be customized as per your need.
Global Serine Protein Kinase Market Report Segments:
The global Serine Protein Kinase market is segmented on the basis of:
Types
AZD-0156, AZD-1390, KU-55933, M-3541, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Colorectal Cancer, Gastric Cancer, Solid Tumor, Adenocarcinoma, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- AstraZeneca Plc
- InteRNA Technologies BV
- Merck KGaA
- Shuttle Pharmaceuticals LLC
- AstraZeneca Plc
Highlights of The Serine Protein Kinase Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- AZD-0156
- AZD-1390
- KU-55933
- M-3541
- Others
- By Application:
- Colorectal Cancer
- Gastric Cancer
- Solid Tumor
- Adenocarcinoma
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Serine Protein Kinase Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Serine protein kinase is an enzyme that catalyzes the transfer of a phosphate group from ATP to serine, resulting in the phosphorylation of proteins. Serine protein kinases are important regulators of cellular signaling pathways and are implicated in a variety of diseases.
Some of the major companies in the serine protein kinase market are AstraZeneca Plc, InteRNA Technologies BV, Merck KGaA, Shuttle Pharmaceuticals LLC, AstraZeneca Plc.
The serine protein kinase market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Serine Protein Kinase Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Serine Protein Kinase Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Serine Protein Kinase Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Serine Protein Kinase Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Serine Protein Kinase Market Size & Forecast, 2020-2028
4.5.1 Serine Protein Kinase Market Size and Y-o-Y Growth
4.5.2 Serine Protein Kinase Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 AZD-0156
5.2.2 AZD-1390
5.2.3 KU-55933
5.2.4 M-3541
5.2.5 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Colorectal Cancer
6.2.2 Gastric Cancer
6.2.3 Solid Tumor
6.2.4 Adenocarcinoma
6.2.5 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Serine Protein Kinase Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Serine Protein Kinase Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 AZD-0156
9.6.2 AZD-1390
9.6.3 KU-55933
9.6.4 M-3541
9.6.5 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Colorectal Cancer
9.10.2 Gastric Cancer
9.10.3 Solid Tumor
9.10.4 Adenocarcinoma
9.10.5 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 AZD-0156
10.6.2 AZD-1390
10.6.3 KU-55933
10.6.4 M-3541
10.6.5 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Colorectal Cancer
10.10.2 Gastric Cancer
10.10.3 Solid Tumor
10.10.4 Adenocarcinoma
10.10.5 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 AZD-0156
11.6.2 AZD-1390
11.6.3 KU-55933
11.6.4 M-3541
11.6.5 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Colorectal Cancer
11.10.2 Gastric Cancer
11.10.3 Solid Tumor
11.10.4 Adenocarcinoma
11.10.5 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 AZD-0156
12.6.2 AZD-1390
12.6.3 KU-55933
12.6.4 M-3541
12.6.5 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Colorectal Cancer
12.10.2 Gastric Cancer
12.10.3 Solid Tumor
12.10.4 Adenocarcinoma
12.10.5 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 AZD-0156
13.6.2 AZD-1390
13.6.3 KU-55933
13.6.4 M-3541
13.6.5 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Colorectal Cancer
13.10.2 Gastric Cancer
13.10.3 Solid Tumor
13.10.4 Adenocarcinoma
13.10.5 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Serine Protein Kinase Market: Competitive Dashboard
14.2 Global Serine Protein Kinase Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 AstraZeneca Plc
14.3.2 InteRNA Technologies BV
14.3.3 Merck KGaA
14.3.4 Shuttle Pharmaceuticals LLC
14.3.5 AstraZeneca Plc
